Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions

Rafael Vidal-Perez1, Charigan Abou Jokh Casas2, Rosa Maria Agra-Bermejo2

  • 1Cardiology Department, Hospital Clinico Universitario de Santiago, Santiago de Compostela 15706, Spain. rafavidal@hotmail.com.

Insights

Myocardial infarction with non-obstructive coronary arteries (MINOCA) presents unique patient profiles and causes compared to type 1 myocardial infarction. Identifying the specific cause of MINOCA is crucial for effective patient care and prognosis.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Acute coronary syndromes encompass myocardial infarction with non-obstructive coronary arteries (MINOCA), distinct from type 1 myocardial infarction.
  • MINOCA patients are often younger, female, and have fewer cardiovascular risk factors, with two-thirds presenting ST-segment elevation.

Purpose of the Study:

  • To differentiate MINOCA from type 1 myocardial infarction.
  • To explore the diverse etiologies, diagnostic approaches, and prognostic implications of MINOCA.

Main Methods:

  • Utilized coronary angiography, left ventriculography, echocardiography, intravascular ultrasound, optical coherence tomography, provocative testing, and cardiac magnetic resonance.
  • Reviewed patient characteristics, clinical presentation, physiopathology, management, and prognosis.

Main Results:

  • MINOCA etiologies include epicardial causes (plaque disruption, dissection, spasm) and microvascular causes (spasm, takotsubo syndrome, myocarditis, thromboembolism).
  • Diagnostic tools aid in identifying specific mechanisms, guiding treatment and prognosis.
  • MINOCA is not benign, with varying prognoses depending on the underlying cause.

Conclusions:

  • MINOCA requires a distinct diagnostic and management strategy compared to type 1 myocardial infarction.
  • Standardized criteria and multi-center trials are needed to optimize cardiovascular care for MINOCA patients.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
813
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
313
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
637
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
191
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
308